Understanding Quality of Life Among Patients With Cancer Receiving Palliative Care

NCT ID: NCT05331625

Last Updated: 2025-11-28

Basic Information

• Recruitment Status: ACTIVE_NOT_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 208 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-11-03
• Study Completion Date: 2026-08-31

Brief Summary

This randomized controlled trial will assess the effects on quality of life of two approaches to symptom management among new patients referred to a palliative care oncology clinic.

Conditions

Cancer

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: SINGLE

Study Groups

Intervention

Participants in this group will consent to participate in a study about quality of life for patients with cancer seeking outpatient palliative care. They will be seen in a palliative care oncology clinic at which time they will be offered additional resources to promote symptom management. They will be asked to complete a series of surveys every two weeks for 16 weeks which will assess their quality of life, symptoms, and medication use.

Group Type: EXPERIMENTAL

Offering Additional Resources to Promote Symptom Management

Intervention Type: BEHAVIORAL

Participants will be offered additional resources to promote symptom management.

Usual Care

Participants in this group will consent to participate in a study about quality of life for patients with cancer seeking outpatient palliative care. They will be seen in a palliative care oncology clinic where they will receive symptom management and supportive care. They will be asked to complete a series of surveys every two weeks for 16 weeks which will assess their quality of life, symptoms, and medication use.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Offering Additional Resources to Promote Symptom Management

Participants will be offered additional resources to promote symptom management.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Be a new patient at an outpatient palliative care clinic
• Resident of Pennsylvania
• Over 18 years of age

Exclusion Criteria

• Prior use of certain symptom focused therapies
• Currently pregnant

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Abramson Cancer Center at Penn Medicine

OTHER

Sponsor Role: lead

Responsible Party

Scott Halpern

Associate Professor of Medicine

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Countries

United States

Other Identifiers

850807

Identifier Type: OTHER

Identifier Source: secondary_id

UPCC 11922

Identifier Type: -

Identifier Source: org_study_id